John W Babich

11PUBLICATIONS
29CO-AUTHORS
Instruments and techniquesMolecular targetsPredictive and prognostic markersPeripheral nervous systemGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Dec 20, 2021
A suitable time point for quantifying the radiochemical purity of 225Ac-labeled radiopharmaceuticals.

James M Kelly, Alejandro Amor-Coarasa, Elizabeth Sweeney

|Mar 15, 2021
A Trifunctional Theranostic Ligand Targeting Fibroblast Activation Protein-α (FAPα).

James M Kelly, Thomas M Jeitner, Shashikanth Ponnala

|Feb 15, 2021
In Vivo Imaging of Fibroblast Activity Using a 68Ga-Labeled Fibroblast Activation Protein Alpha (FAP-α) Inhibitor: Study in a Mouse Rotator Cuff Repair Model.

Xueying Zhang, Daoyun Chen, John W Babich

|Sep 01, 2020
Meeting report from the Prostate Cancer Foundation PSMA theranostics state of the science meeting.

Andrea K Miyahira, Kenneth J Pienta, John W Babich

|Apr 15, 2020
Preclinical Evaluation of a High-Affinity Sarcophagine-Containing PSMA Ligand for 64Cu/67Cu-Based Theranostics in Prostate Cancer.

James M Kelly, Shashikanth Ponnala, Alejandro Amor-Coarasa

|Apr 10, 2020
A general 11C-labeling approach enabled by fluoride-mediated desilylation of organosilanes.

Wenchao Qu, Bao Hu, John W Babich

Pageof 2